Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Ling-Di Li"'
Autor:
Nan Xu, Kai Sun, Ya-Zhe Wang, Wen-Min Chen, Jun Wang, Ling-Di Li, Xu Wang, Yue Hao, Yan Chang, Yan-Rong Liu, Xiao-Jun Huang, Ya-Zhen Qin
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundAcute myeloid leukemia (AML) with t(8;21) needs to be further stratified. In addition to leukemia cells, immune cells in tumor microenvironment participate in tumor initiation, growth and progression. Interleukins (ILs)/interleukin receptor
Externí odkaz:
https://doaj.org/article/58a614ad78414028890de72f446b418e
Autor:
Jun Wang, Kai Sun, Wen-Min Chen, Xu Wang, Ling-Di Li, Yue Hao, Nan Xu, Hao Jiang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Xiao-Jun Huang, Qian Jiang, Ya-Zhen Qin
Publikováno v:
Leukemia & Lymphoma. 64:698-706
Autor:
Nan Xu, Wen-Min Chen, Ling-Di Li, Ling-Yu Long, Xu Wang, Qian Jiang, Hao Jiang, Xiao-Jun Huang, Ya-Zhen Qin
Publikováno v:
Clinical and Experimental Medicine.
Autor:
Kai Sun, Wen‐Min Chen, Xu Wang, Xiao‐Su Zhao, Ling‐Di Li, Yue Hao, Jun Wang, Nan Xu, Qian Jiang, Hao Jiang, Lan‐Ping Xu, Yu Wang, Xiao‐Hui Zhang, Xiao‐Jun Huang, Ya‐Zhen Qin
Publikováno v:
Hematological oncology.
N/A This article is protected by copyright. All rights reserved.
Autor:
null Kai Sun, null Wen‐Min Chen, null Xu Wang, null Xiao‐Su Zhao, null Ling‐Di Li, null Yue Hao, null Jun Wang, null Nan Xu, null Qian Jiang, null Hao Jiang, null Lan‐Ping Xu, null Yu Wang, null Xiao‐Hui Zhang, null Xiao‐Jun Huang, null Ya‐Zhen Qin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36fe918b9da2bfb1784cb53e61622cda
https://doi.org/10.1002/hon.3114/v2/response1
https://doi.org/10.1002/hon.3114/v2/response1
Autor:
Jun Wang, Xiao-Hui Zhang, Ya-Zhen Qin, Lu Yang, Ling-Yu Long, Hao Jiang, Qian Jiang, Yan-Rong Liu, Ling-Di Li, Wen-Min Chen, Feng-Ting Dao
Publikováno v:
Leukemia & Lymphoma. 62:185-193
Acute myeloid leukemia with intermediate cytogenetic risk (ICR-AML) needs to be stratified and abnormal gene expression might be prognostic. PR/SET domain 16 (PRDM16) transcript levels were assesse...
Autor:
Ya-Zhe Wang, Yan Chang, Ling-Di Li, Jin Lu, Ya-Zhen Qin, Ling-Yu Long, Yan-Rong Liu, Kai-Yan Liu, Lu Yang, Feng-Ting Dao, Wen-Min Chen
Publikováno v:
OncoTargets and Therapy. 13:7545-7553
Purpose The cancer-testis antigen, which is a preferentially expressed antigen of melanoma (PRAME), is an ideal target for immunotherapy and cancer vaccines. Since the expression of this antigen is relevant to therapy responses, the heterogeneity in
Autor:
Yan-Rong Liu, Lu Yang, Ai-Dong Lu, Wen-Min Chen, Le-Ping Zhang, Kai-Yan Liu, Ling-Di Li, Feng-Ting Dao, Ling-Yu Long, Ya-Zhen Qin
Publikováno v:
Pediatric hematology and oncology. 39(2)
Abnormally high ecotropic viral integration site 1 (EVI1) expression has been recognized as a poor prognostic factor in acute myeloid leukemia patients. However, its prognostic impact in B cell precursor acute lymphoblastic leukemia (BCP-ALL) remains
Autor:
Feng-Ting, Dao, Wen-Min, Chen, Ling-Yu, Long, Ling-Di, Li, Lu, Yang, Jun, Wang, Yan-Rong, Liu, Hao, Jiang, Xiao-Hui, Zhang, Qian, Jiang, Ya-Zhen, Qin
Publikováno v:
Leukemialymphoma. 62(1)
Acute myeloid leukemia with intermediate cytogenetic risk (ICR-AML) needs to be stratified and abnormal gene expression might be prognostic. PR/SET domain 16 (
Autor:
Ling-Yu Long, Yan Chang, Yan-Rong Liu, Ya-Zhe Wang, Lu Yang, Ling-Di Li, Yan-Huan Zhang, Jin Lu, Ya-Zhen Qin, Wen-Min Chen, Hong-Hu Zhu
Publikováno v:
DNA and Cell Biology. 36:1099-1107
Multiple myeloma (MM) patients commonly present abnormal expression of cancer-testis antigens, which may serve as immunotherapeutic targets and prognostic factors. We previously reported that preferentially expressed antigen of melanoma (PRAME) overe